| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 23, 2011
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 23, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the 30th Annual JP Morgan...
-
Dec 9, 2011Neurostimulator with Innovative Motion Sensor Technology Was Recently Approved by the FDA for the Management of Chronic Pain
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 9, 2011-- Clinical trial data presented at the 15th Annual Meeting of the North American Neuromodulation Society demonstrate the AdaptiveStim™ with...
-
Nov 17, 2011
MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE:MDT) and Bain Capital, a leading global private investment firm, today announced they have entered into a definitive...
-
Nov 8, 2011Pooled Data Analyses to Be Presented at TCT 2011 Demonstrate Heart Device's Consistently Positive Performance Across Multiple Clinical Studies
SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT)...
-
Nov 8, 2011Final Five-Year Follow-up of Randomized ENDEAVOR IV Trial Shows Durable Safety and Efficacy of Endeavor DES, with Comparatively Lower Rates of Cardiac Death/Myocardial Infarction and Very Late Stent Thrombosis
SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- New research findings released at TCT 2011 show that the Endeavor(R) zotarolimus-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT) outperformed...
-
Nov 4, 2011Presentations Cover Stents and Balloons for Coronary and Peripheral Artery Disease, Transcatheter Valve for Aortic Stenosis, Stent Grafts for Aortic Aneurysms, and Renal Denervation for Treatment-Resistant Hypertension and Heart Failure
MINNEAPOLIS, Nov 04, 2011 (BUSINESS WIRE) -- Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT)...
-
Nov 3, 2011The latest advancement in expandable cage technology for surgeons, hospitals and patients
MEMPHIS, Tenn., Nov 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced the global launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device in the U.S. and Europe today at the North...
-
Nov 2, 2011
MEMPHIS, Tenn., Nov 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today a pioneering approach to minimally invasive spinal fusion at the 26th
-
Nov 2, 2011
MINNEAPOLIS, Nov 02, 2011 (BUSINESS WIRE) -- To address surgeon needs of rapidly managing hemostasis in minimally invasive spine surgery, Medtronic, Inc. (NYSE: MDT) announced today the launch of...
-
Oct 26, 2011U.S. Clinical Trial of Symplicity(R) Renal Denervation System(TM) Enrolls First Patient
MINNEAPOLIS, Oct 26, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity(R) Renal Denervation...
-
Sep 12, 2011New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications
MEMPHIS, Tenn., Sep 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today the U.S. launch of its ARTISAN(TM) Space Maintenance System. The device is cleared for temporary use in...
-
Sep 8, 2011Index Acknowledge Corporate Sustainability Accomplishments
MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
-
Aug 31, 2011Medtronic Expands Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient...
-
Aug 5, 2011
MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
-
Jul 25, 2011Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval
MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
-
Jul 11, 2011Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon
MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...
-
Jul 7, 2011Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...
-
Jul 7, 2011Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...
-
Jun 23, 2011
MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...
-
Jun 18, 2011Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study
MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...
-
Jun 3, 2011
MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...
-
May 24, 2011Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...
-
May 24, 2011
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
-
May 5, 2011Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions,...
-
May 5, 2011
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...